Navigation Links
BiOptix Announces Additional $1.4M in Funding to Aid in Commercialization and Working Capital Needs
Date:8/13/2014

BOULDER, Colo., Aug. 13, 2014 /PRNewswire/ -- BiOptix announced today an additional $1.4M financing from existing investors.  The funds will be used to expand sales and marketing and ramp up manufacturing to meet growing customer demand. 

Rick Whitcomb, President and CEO of BiOptix, noted:  "This latest increase in capital shows that our investors are confident in our plan and our team, and that BiOptix is on a solid path to commercial success."  BiOptix continues to see opportunity in the label-free marketplace, which is looking for a high quality, high performance SPR instrument at a reasonable price. "We are making great inroads in the marketplace, and this infusion of capital will aid our efforts to reach as many scientific researchers as possible," commented Whitcomb.

Surface Plasmon Resonance (SPR) is an advanced and highly sensitive optical technology that measures refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic rates and affinity constants. BiOptix has developed and patented a novel ultra-sensitive detection platform known as Enhanced Surface Plasmon Resonance, or ESPR. Unlike traditional SPR, ESPR instrumentation from BiOptix marries the high sensitivity of SPR with the high stability and lower noise of common path interferometry.

About BiOptix

BiOptix Diagnostics is a privately held firm based in Boulder, Colorado, with leading investments from Boulder Ventures, Remeditex and Rusnano.  BiOptix has developed a new class of analytical biosensor instrumentation utilizing ESPR – Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interaction—with high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements. Additional information about BiOptix and our products can be found at:  www.bioptix.com


'/>"/>
SOURCE BiOptix
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. BiOptix announces expansion of Innovators Program into Europe
2. BiOptix announces low cost Surface Plasmon Resonance Services for Colorado-based researchers
3. BiOptix to highlight new carbonic anhydrase data at IBCs Biopharmaceutical Development & Production Week
4. BiOptix announces expansion of Innovators Program at Molecular Med TRI-CON 2013
5. BiOptix Announces Fall 2012 Tradeshow and Symposia Schedule
6. Perrigo Company plc Announces Quarterly Dividend
7. Kindred Biosciences Announces Second Quarter 2014 Financial Results
8. Imprimis Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Operational Update
9. WuXi PharmaTech Announces Second-Quarter 2014 Results
10. Nutrastar International Inc. Announces Second Quarter 2014 Results
11. Novogen Announces Results of General Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2017)... 50 years ago today, the Monterey Pop Festival opened its ... San Francisco "Summer of Love."  To celebrate the anniversary, Northern ... strategic market research portals that it will begin delivering to ... Light,s "Summer of Love (For Our Customers)."  ... Northern ...
(Date:6/14/2017)... , June 14, 2017 The Bio ... City of Fremont and the ... the bio-pharma industry in California ... enabling executive networking, and fostering workforce development. The primary ... and growth of start-ups, as well as small and ...
(Date:6/13/2017)... WARSAW, Ind. , June 13, 2017 Zimmer ... in musculoskeletal healthcare, today announced that the U.S. Food and ... Letter dated June 3, 2015 relating to its ... "The successful clearance of ... China manufacturing facility is a measure of the ...
Breaking Medicine Technology:
(Date:6/27/2017)... ... 2017 , ... Today, June 27th is PTSD Awareness Day. Over half a ... receive adequate care due to lack of effective treatments, fear of stigma or insufficient ... left untreated, veterans are at an increased risk for self-destructive behavior, including alcohol/drug abuse, ...
(Date:6/27/2017)... ... June 27, 2017 , ... Children’s National Health System ... rankings, with its Neonatology program ranking #1 out of more than 1500 neonatal ... to the coveted Honor Roll, a distinction given to the top performing children’s hospitals ...
(Date:6/26/2017)... ... June 26, 2017 , ... Dr. Martin Bastuba, MD, ... collaboration with the Fertility Center of California, is pleased to announce the addition ... aspiration) and TESA (percutaneous testicular sperm extraction). These minimally invasive treatments are primarily ...
(Date:6/26/2017)... ... June 26, 2017 , ... A ... revolutionizing the way women look and feel about themselves and their sexual encounters. ... sexual dysfunction and urinary leakage head on with a ground breaking medical technique ...
(Date:6/26/2017)... ... June 26, 2017 , ... KICKICO , a protocol built ... pledges to solve many catastrophic issues within funding campaigns. KICKICO developers are testing the ... of crowdfunding - the raising of funds through the power of many - has ...
Breaking Medicine News(10 mins):